'Grand alliance' failed to take off as Rahul Gandhi did not override local satraps: Tarun Gogoi

Agencies
March 29, 2019

Guwahati, Mar 29: The opposition's anti-BJP 'grand alliance' failed to take the desired shape as Congress president Rahul Gandhi chose not to "override" the sentiments of state leaders who did not favour the move, party veteran and thrice Assam chief minister Tarun Gogoi said.

Gogoi, a six-term former MP and union minister, also rubbished the BJP's allegation of the Congress being a "dynastic" party, insisting it was the "most democratic" in the country.

He said despite the opposition alliance being nebulous because of lack of formal tie-ups, the anti-BJP parties were united in their intent of defeating the saffron party and its allies.

"Rahul Gandhi was keen on alliance most of the time. But the local party leaders said no. Our party gives importance to regional leadership. That is why we have not been able to form alliances in many places," Gogoi told PTI in an interview.

"Though the Congress is often dubbed as a dynastic party, it is the most democratic party. Rahul Gandhi does not override the sentiments of local leaders who are heard and given due importance," he said.

Gogoi, when asked if a pre-poll pact between potential partners of the proposed grand alliance could have got them more seats, said nobody can predict that with any amount of certainty.

The Assam leader also appeared to favour the largest party in a winning coalition deciding which direction the government would take.

"Even in case of alliance, the largest party can administer and rule the country. That is also needed. The single largest party must have sufficient strength so that it is not dependent on alliance all the time. Otherwise, the alliance (its smaller constituents) will dictate. And that is not a good for the country," he said.

Referring to the seat sharing agreement between the Congress and CPI(M) for the West Bengal assembly elections in 2016, he said it was not beneficial as "sometimes alliances do not help and go against our own interest".

The Congress leader conceded that uniting all opposition parties on one platform is not an easy task as ideological differences and reluctance to cede political space to each other often come in the way.

"Yes, votes get divided because of this. But who will make the sacrifice? Nobody will sacrifice. Why should we leave our seat when the other party doesn't? Yes, is will be better if things are done in the spirit of give and take, but that is not possible because of divergence and differences among us," he said.

Gogoi was responding to a question about division of secular votes in 2014 that helped BJP secure a majority in the Lok Sabha on its own, the strongest public mandate secured by any party since 1984 when the Congress had won a landslide.

"How much vote did they (BJP) get last time? Only 31 per cent. He (Modi) only gave an impression that he is the most popular prime minister. Probably, he is the only one to become the prime minister with lowest percentage of votes," Gogoi said.

When asked about Congress's failure to clinch an electoral pact with the CPI(M) in West Bengal, the former chief minister said it was because the two were on the rival side of the political divide in Kerala.

"If we praise them here, how will we criticise them there?"

He, however, insisted all opposition parties were unanimous in their view that they must fight the Narendra Modi government's "dictatorial and pro-rich" policies.

The Congress veteran leader claimed the Centre's assertions on development were "sheer propaganda".

"Farm distress, job loss, slowdown in construction and manufacturing, failure to check price rise, fall in exports and decline in GDP....Overall the the Indian economy is in a bad shape. Indications are that the country is on decline. It is not moving up, but going down," he claimed.

Gogoi was, however, optimistic about the Congress's prospects in the elections despite the opposition alliance failing to take off the way it should have.

"The Congress's prospects this time are very good. I think it will get around 200 seats. Indian people are intelligent. They would sometimes punish and then reward," he said, apparently the party's lowest ever tally of 44 seats in 2014 LS polls weighing on his mind.

He also maintained the BJP's tally in states like Uttar Pradesh, Gujarat, Maharashtra, Chhattisgarh, Rajasthan and Madhya Pradesh, where it had scored impressive victories like never before, will go down.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 11,2020

New Delhi, Jun 11: The death toll due to COVID-19 rose to 8,102 and the number of cases climbed to 2,86,579 in the country after it registered the highest single-day spike of 357 fatalities and 9,996 cases till Thursday 8 AM, according to the Union Health Ministry data.

The number of recoveries remained more than the active novel coronavirus cases for the second consecutive day.

The number of active cases stands at 1,37,448 while 1,41,028 people have recovered and one patient has migrated to another country, as per the data.   

"Thus, around 49.21 per cent patients have recovered so far," an official said.

The total number of confirmed cases include foreigners.

Of the 357 new deaths reported till Thursday morning, 149 were in Maharashtra, 79 in Delhi, 34 in Gujarat, 20 in Uttar Pradesh, 19 in Tamil Nadu, 17 in West Bengal, eight in Telangana, seven each in Madhya Pradesh and Haryana, four in Rajasthan, three each in Jammu and Kashmir and Karnataka, two each in Kerala and Uttarakhand, one each in Andhra Pradesh, Bihar and Himachal Pradesh.

Out of the total 8,102 fatalities, Maharashtra tops the tally with 3,438 deaths followed by Gujarat with 1,347 deaths, Delhi with 984, Madhya Pradesh with 427, West Bengal with 432, Tamil Nadu with 326, Uttar Pradesh with 321, Rajasthan with 259 and Telangana with 156 deaths.

The death toll reached 78 in Andhra Pradesh, 69 in Karnataka and 55 in Punjab. Jammu and Kashmir has reported 51 fatalities due to the coronavirus disease, while 52 deaths have been reported from Haryana, 33 from Bihar, 18 from Kerala, 15 from Uttarakhand, nine from Odisha and eight from Jharkhand.

Chhattisgarh and Himachal Pradesh have registered six COVID-19 fatalities each, Chandigarh has five while Assam has recorded four deaths so far. Meghalaya, Tripura and Ladakh have reported one COVID-19 fatality each, according to the ministry's data.

More than 70 per cent of the deaths are due to comorbidities, the ministry's website stated.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 3,2020

Daman, Mar 3: A BJP councillor was shot dead on Monday in the Union Territory of Daman, police said.

Salim Memon was sitting in his motorcycle showroom when three to four unidentified persons shot four to five bullets after asking a visitor there to move out, an official said quoting eye-witnesses.

While fleeing, they also shot two rounds close to this visitor who was standing outside, he said.

"Memon was rushed to a hospital in Marwad area but was declared dead on arrival. CCTV footage is being scanned to nab the culprits," said Daman Superintendent of Police Vikramjit Singh.

Memon was elected to Daman municipality as a Congress candidate but then switched over to the BJP.

Sources said Memon, who also has a land brokerage business, had come out of jail a few months back in connection with a case of rivalry.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.